HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$2.75
+0.08 (+3.00%)
As of Aug 8, 2:24 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +486.9% upside
Low Target $9.68
Average Target $16.14
High Target $20.98
Current Price $2.75
Current
$2.75
Target
$16.14
$9.68 $16.14 avg $20.98
Scenario Analysis
Bear Case
$9.68
252.0%
Low target
Base Case
$16.14
+486.9%
Avg target
Bull Case
$20.98
+662.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$15.00
-81.7% from high
52-Week Low
$2.34
+17.5% from low
Target vs 52W High
$16.14
+7.6% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
3d
until earnings
EPS Est: $0.94
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%